Press releases.

2026202520242023202220212020201920182017201620152014
Dec 01, 2021
News
IR
English
Corporate Information
Sales
Order
SenzaGen receives SEK 1m follow-on order for GARD®skin Dose-Response from one of the world’s largest cosmetics companies
Nov 02, 2021
News
IR
English
Regulatory
Listing Regulation
Corporate Action
Shares
Issuance
SenzaGen has completed the acquisition of VitroScreen S.r.l.
Oct 29, 2021
News
IR
English
Regulatory
MAR
Corporate Action
Shares
Issuance
SenzaGen completes a directed share issue of SEK 30 million
Oct 28, 2021
News
IR
English
Regulatory
MAR
Corporate Action
Shares
Issuance
SenzaGen intends to carry out a directed share issue
Oct 28, 2021
News
IR
English
Regulatory
MAR
Corporate Action
M&A
SenzaGen enters into agreement to acquire 100 percent of the shares in VitroScreen
Sep 29, 2021
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
SenzaGen presents accelerated growth strategy and invitation to Capital Markets Day
Aug 24, 2021
News
IR
English
Corporate Information
Sales
Order
SenzaGen receives SEK 0.7m order for GARD®skin from one of the world’s largest pharmaceuticals companies
Aug 19, 2021
News
IR
English
Regulatory
MAR
Report
Interim
Q2
SenzaGen’s 2021 Half-Year Report: Positive ESAC opinion on GARD®skin and expanded range of tests open up new commercial opportunities
Aug 18, 2021
News
IR
English
Regulatory
MAR
Corporate Information
Staff change
SenzaGen appoints Peter Nählstedt as new CEO
Aug 12, 2021
News
IR
English
Corporate Information
Other Corporate Information
Invitation to SenzaGen’s 2021 half year report conference call on Aug 19 at 10.30 CET
Aug 06, 2021
News
IR
English
Corporate Information
Sales
Order
SenzaGen receives SEK 0.65 million order for in vitro skin allergy and irritation tests from global consumer product company
Jul 26, 2021
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
Positive scientific ESAC opinion on GARD®skin paves the way for OECD validation and opens new commercial opportunities
Jul 12, 2021
News
IR
English
Corporate Information
Sales
Order
SenzaGen and RIFM begin part two of the GARD®skin Dose-Response program
Jul 09, 2021
News
IR
English
Corporate Information
Sales
Order
SenzaGen receives SEK 0.65 million order for GARD®skin Dose-Response from one of the world's leading cosmetics companies
May 24, 2021
News
IR
English
Corporate Information
Other Corporate Information
SenzaGen expands services within in vitro skin toxicology
May 05, 2021
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Report of the AGM
Report from AGM of SenzaGen AB on 5 May 2021
Mar 26, 2021
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
NOTICE OF ANNUAL GENERAL MEETING OF SENZAGEN AB (Publ)
Mar 25, 2021
News
IR
English
Regulatory
Listing Regulation
Report
Annual
SenzaGen’s Annual Report 2020 published
Mar 04, 2021
News
IR
English
Corporate Information
Sales
Order
SenzaGen and RIFM expand collaboration on the safe use of fragrances with GARD™skin Dose-Response
Feb 26, 2021
News
IR
English
Corporate Information
Sales
Order
SenzaGen secures SEK 0.6 m order from a new European customer in the chemical industry
Next